If the result of the clinical trial proves the antibiosis of copper, it will be assessed to be remarkable achievement to boost the demand for copper and to suggest an alternative to prevent the infection of diseases at hospitals. In Korea, infection of diseases is a big issue at most hospitals at present, as the second-largest cause for the outbreak of diseases is infection in Korea.
展开▼